• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病严重加重的轨迹及其与死亡风险的关系。

Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk.

机构信息

Servicio de Neumología, Hospital Universitario Lucus Augusti, Unidad Administrativa 4-A, C/Dr Ulises Romero, 1, 27002, Lugo, Spain.

Servicio de Neumología y Cirugía Torácica, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.

出版信息

Lung. 2022 Oct;200(5):601-607. doi: 10.1007/s00408-022-00565-8. Epub 2022 Sep 5.

DOI:10.1007/s00408-022-00565-8
PMID:36065068
Abstract

PURPOSE

Acute exacerbations of COPD (AECOPD) are important factors contributing to mortality risk. The rate of exacerbations varies overtime. An inconsistent pattern of exacerbation occurrence is a common finding. The mortality risk associated with such a pattern is not entirely clear. Our objective was to assess the risk of mortality associated with various possible patterns of AECOPD trajectories.

METHODS

This is a multicenter historical cohort study. Four different exacerbation trajectories were defined according to the incidence of severe AECOPD requiring hospital admission 2 years before and after the date of the first visit to the respiratory clinic-Consistent non-exacerbators (NEx): no AECOPD before or after the index date; consistent exacerbators (Ex): at least one AECOPD both before and after the index date; converters to exacerbators (CONV-Ex): no exacerbations before and at least one AECOPD after the index date; converters to non-exacerbators (CONV-NEx): at least one AECOPD before the index date, and no exacerbations after said date. All-cause mortality risk for these trajectories was assessed.

RESULTS

A total of 1713 subjects were included in the study: NEx: 1219 (71.2%), CONV-NEx: 225 (13.1%), CONV-Ex: 148 (8.6%), Ex: 121 (7.1%). After correcting for confounding variables, the group with the highest mortality risk was Ex. The CONV-Ex and CONV-Nex groups had a mortality risk between Ex and NEx, with no significant differences between them.

CONCLUSION

Different possible trajectories of severe AECOPD before and after a first specialized consultation are associated with different mortality risks. An inconsistent pattern of exacerbations has a mortality risk between Ex and NEx, with no clear differences between CONV-Ex and CONV-NEx.

摘要

目的

COPD(慢性阻塞性肺疾病)急性加重(AECOPD)是导致死亡风险的重要因素。加重的发生率随时间而变化。加重发生的模式不一致是常见的发现。与这种模式相关的死亡风险尚不完全清楚。我们的目的是评估与各种可能的 AECOPD 轨迹模式相关的死亡风险。

方法

这是一项多中心历史队列研究。根据首次就诊前 2 年和首次就诊后发生需要住院治疗的严重 AECOPD 的发生率,定义了四种不同的加重轨迹:一致非加重者(NEx):在指数日期前后均无 AECOPD;一致加重者(Ex):在指数日期前后均至少有一次 AECOPD;加重者转为非加重者(CONV-NEx):在指数日期前无加重,且在指数日期后至少有一次 AECOPD;非加重者转为加重者(CONV-Ex):在指数日期前至少有一次加重,且在指数日期后无加重。评估了这些轨迹的全因死亡风险。

结果

共纳入 1713 例患者:NEx:1219(71.2%),CONV-NEx:225(13.1%),CONV-Ex:148(8.6%),Ex:121(7.1%)。在纠正混杂变量后,死亡风险最高的是 Ex 组。CONV-Ex 和 CONV-NEx 组的死亡风险介于 Ex 和 NEx 之间,两者之间无显著差异。

结论

首次专科就诊前后严重 AECOPD 的不同可能轨迹与不同的死亡风险相关。加重模式不一致的患者的死亡风险介于 Ex 和 NEx 之间,CONV-Ex 和 CONV-NEx 之间无明显差异。

相似文献

1
Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk.慢性阻塞性肺疾病严重加重的轨迹及其与死亡风险的关系。
Lung. 2022 Oct;200(5):601-607. doi: 10.1007/s00408-022-00565-8. Epub 2022 Sep 5.
2
Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators.中性粒细胞与淋巴细胞比值预测频繁加重 COPD 急性加重期患者的临床转归。
Int J Chron Obstruct Pulmon Dis. 2021 Feb 17;16:341-349. doi: 10.2147/COPD.S290422. eCollection 2021.
3
Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?频繁的中度加重是否会导致戒烟者慢性阻塞性肺疾病的进展?
Int J Chron Obstruct Pulmon Dis. 2015 Mar 10;10:525-33. doi: 10.2147/COPD.S76475. eCollection 2015.
4
The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.抑郁症状与 COPD 患者急性加重率的相关性:ECLIPSE 队列 3 年纵向随访研究结果。
J Am Med Dir Assoc. 2017 Nov 1;18(11):955-959.e6. doi: 10.1016/j.jamda.2017.05.024. Epub 2017 Jul 18.
5
Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.高风险慢性阻塞性肺疾病门诊患者中的他汀类药物:对首次加重时间和全因死亡率无影响 - STATUETTE 队列研究。
Int J Chron Obstruct Pulmon Dis. 2021 Mar 5;16:579-589. doi: 10.2147/COPD.S296472. eCollection 2021.
6
Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.普通人群中频繁 COPD 加重者的稳定性:一项丹麦全国基于登记的研究。
NPJ Prim Care Respir Med. 2017 Apr 17;27(1):25. doi: 10.1038/s41533-017-0029-7.
7
Incidence and profile of severe exacerbations of chronic obstructive pulmonary disease due to biomass smoke or tobacco.生物质烟雾或烟草导致的慢性阻塞性肺疾病严重加重的发病率及特征
Ann Thorac Med. 2022 Oct-Dec;17(4):193-198. doi: 10.4103/atm.atm_155_22. Epub 2022 Oct 7.
8
Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Are There Significant Differences Between Hospitalized and Emergency Department Patients?慢性阻塞性肺疾病急性加重:住院患者和急诊科患者之间有显著差异吗?
Int J Chron Obstruct Pulmon Dis. 2024 Jan 16;19:133-138. doi: 10.2147/COPD.S447477. eCollection 2024.
9
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.慢性阻塞性肺疾病恶化和心脏事件。SUMMIT 随机临床试验的事后队列分析。
Am J Respir Crit Care Med. 2018 Jul 1;198(1):51-57. doi: 10.1164/rccm.201711-2239OC.
10
Mortality, seasonal variation, and susceptibility to acute exacerbation of COPD in the pandemic year: a nationwide population study.在大流行的一年中,COPD 的死亡率、季节性变化和急性加重易感性:一项全国性人群研究。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221081047. doi: 10.1177/17534666221081047.

引用本文的文献

1
The Relevance of Comorbidities in the Persistence of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者共病与急性加重持续存在的相关性
Open Respir Arch. 2023 May 8;5(3):100249. doi: 10.1016/j.opresp.2023.100249. eCollection 2023 Jul-Sep.
2
Association between serum phosphate and in-hospital mortality of patients with AECOPD: A retrospective analysis on eICU database.慢性阻塞性肺疾病急性加重期(AECOPD)患者血清磷水平与院内死亡率的相关性:基于电子重症监护病房(eICU)数据库的回顾性分析
Heliyon. 2023 Sep 6;9(9):e19748. doi: 10.1016/j.heliyon.2023.e19748. eCollection 2023 Sep.
3
LUNG Year in Review: 2022.

本文引用的文献

1
Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study.COPD 加重的频率和严重程度与未来加重和死亡风险的关系:一项英国常规医疗保健数据研究。
Int J Chron Obstruct Pulmon Dis. 2022 Mar 3;17:427-437. doi: 10.2147/COPD.S346591. eCollection 2022.
2
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS.布地奈德/格隆溴铵/富马酸福莫特罗气雾剂改善无近期加重史 COPD 患者的加重结局:KRONOS 的亚组分析。
Int J Chron Obstruct Pulmon Dis. 2021 Jan 28;16:179-189. doi: 10.2147/COPD.S286087. eCollection 2021.
3
《2022年肺部疾病年度回顾》
Lung. 2023 Feb;201(1):1-4. doi: 10.1007/s00408-022-00594-3. Epub 2023 Jan 30.
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
在 COPD 中,是否应以前一年的急性加重次数来指导治疗?
Eur Respir J. 2021 Feb 11;57(2). doi: 10.1183/13993003.02122-2020. Print 2021 Feb.
4
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.中重度至极重度 COPD 患者两种糖皮质激素剂量三联吸入治疗。
N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24.
5
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial.布地奈德/格隆溴铵/富马酸福莫特罗联合混悬液给药技术三联疗法对比慢性阻塞性肺疾病(KRONOS)中的双联疗法:一项双盲、平行分组、多中心、3 期随机对照临床试验。
Lancet Respir Med. 2018 Oct;6(10):747-758. doi: 10.1016/S2213-2600(18)30327-8. Epub 2018 Sep 16.
6
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.COPD 患者每日一次单吸入器三联与双联治疗。
N Engl J Med. 2018 May 3;378(18):1671-1680. doi: 10.1056/NEJMoa1713901. Epub 2018 Apr 18.
7
The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology.慢性阻塞性肺疾病既往与未来严重加重之间的关联:使用稳健统计方法更新文献。
PLoS One. 2018 Jan 19;13(1):e0191243. doi: 10.1371/journal.pone.0191243. eCollection 2018.
8
Defining the "Frequent Exacerbator" Phenotype in COPD: A Hypothesis-Free Approach.COPD 中“频繁加重者”表型的定义:一种无假设方法。
Chest. 2018 May;153(5):1106-1115. doi: 10.1016/j.chest.2017.10.009. Epub 2017 Oct 17.
9
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.慢性阻塞性肺疾病患者的加重频率:SPIROMICS 队列分析。
Lancet Respir Med. 2017 Aug;5(8):619-626. doi: 10.1016/S2213-2600(17)30207-2. Epub 2017 Jun 28.
10
Factors associated with change in exacerbation frequency in COPD.与 COPD 加重频率变化相关的因素。
Respir Res. 2013 Jul 30;14(1):79. doi: 10.1186/1465-9921-14-79.